Key Takeaways & Executive Findings
- •• Transitive siRNAs are generated via RDR-dependent synthesis of dsRNA, enabling amplification and spread of RNAi silencing signals beyond primary targets. • In Arabidopsis, RDR1 and RDR6 cooperate with RISC and aberrant RNAs to produce transitive siRNAs in diverse subcellular compartments, revealing complex regulatory mechanisms. • Transitive siRNAs play crucial roles in plant development and stress adaptation, with potential applications in crop improvement and biotechnology. • The review highlights unresolved questions regarding RDR recruitment and the full spectrum of transitive siRNA functions, guiding future research.
Abstract
Small RNA (sRNA)-mediated RNA interference (RNAi) is a sequence-specific gene silencing mechanism that modulates gene expression in eukaryotes. As core molecules of RNAi, various sRNAs are encoded in the plant genome or derived from invading RNA molecules, and their biogenesis depends on distinct genetic pathways. Transitive small interfering RNAs (siRNAs), which are sRNAs produced from double-strand RNA (dsRNA) in a process that depends on RNA-dependent RNA polymerases (RDRs), can amplify and spread silencing signals to additional transcripts, thereby enabling a phenomenon termed “transitive RNAi”. Members of this class of siRNAs function in various biological processes ranging from development to stress adaptation. In Arabidopsis thaliana, two RDRs participate in the generation of transitive siRNAs, acting cooperatively with various siRNA generation-related factors, such as the RNA-induced silencing complex (RISC) and aberrant RNAs. Transitive siRNAs are produced in diverse subcellular locations and structures under the control of various mechanisms, highlighting the intricacies of their biogenesis and functions. In this review, we discuss recent advances in understanding the molecular events of transitive siRNA biogenesis and its regulation, with a particular focus on factors involved in RDR recruitment. We aim to provide a comprehensive description of the generalized mechanism governing the biogenesis of transitive siRNAs. Additionally, we present an overview of the diverse biological functions of these siRNAs and raise some pressing questions in this area for further investigation.
1. Introduction
Small RNA-mediated RNAi plays an important role in regulating the expressions of the appropriate genes at the appropriate time and place. This is critical for the development of eukaryotic organisms and their adaptation to environmental stimuli [1,2]. In plants, RNAi is triggered by the presence of double-stranded RNA (dsRNA) or single-stranded RNA (ssRNA) molecules that possess a dsRNA region. These dsRNAs are processed into 21- to 24-nucleotide (nt) small RNA duplexes by DICER-LIKE proteins (DCLs) [1]. The resulting sRNA duplex is 2′-O-methylated at the 3′ end by HUA ENHANCER 1 (HEN1), and is subsequently incorporated into ARGONAUTE (AGO) proteins to form a pre-RNA-induced silencing complex (pre-RISC) [3,4]. After ejection of passenger strand of sRNA, the mature RISC could guide the gene silencing process through complimentary base-pairing [3,4]. Based on the particular AGO proteins found in a RISC and the nature of the target RNA, RNAi can cause either transcriptional gene silencing (TGS) via epigenetic modifications of chromatin or posttranscriptional gene silencing (PTGS) via RNA cleavage or repression of translation [5,6].
An interesting characteristic of sRNA-mediated gene silencing, beyond its ability to silence genes with complementary sequences, is that its silencing effect can be amplified and spread. Gene silencing driven by primary siRNAs, which mostly originate from spontaneously formed dsRNA without amplification by RDRs, is typically restricted to silencing the initiating loci and/or primary targets. In contrast, recruiting RDR to the target RNA via primary siRNAs or miRNAs usually causes the synthesis of dsRNA, which in turn generates secondary siRNAs. This process can lead to the propagation of the silencing signals to target sequences other than the inducer sequence, causing transitive RNAi [7,8]. Thus, secondary siRNAs are also referred to as transitive siRNAs. Recent studies have found that, besides sRNA, many other factors can recruit RDR to given RNAs (discussed below). Once recruited, RDRs extend the RNA to synthesize long dsRNA, thereby producing siRNAs with different sequences. These siRNAs not only silence the cognate genes but also have the potential to target other genes with homologous sequences. Therefore, we also category this class of siRNAs as transitive siRNAs.
Loading authentic research manuscript (Pages 1–5)...
Huijun Tan, Yuelin Liu, Hongwei Guo (2026). The biogenesis, regulation and functions of transitive siRNA in plants. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2024160
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What are transitive siRNAs in plants?
Transitive siRNAs are small interfering RNAs produced from double-stranded RNA (dsRNA) synthesized by RNA-dependent RNA polymerases (RDRs). They amplify and spread RNAi silencing signals to additional transcripts, enabling a phenomenon called transitive RNAi.
How are transitive siRNAs generated?
Transitive siRNAs are generated when RDRs are recruited to target RNAs, often via primary siRNAs or miRNAs, and synthesize long dsRNA. This dsRNA is then processed by DICER-LIKE proteins into secondary siRNAs that can silence additional genes with homologous sequences.
What is the role of RDRs in transitive siRNA biogenesis?
RDRs (RNA-dependent RNA polymerases) are key enzymes that synthesize dsRNA from single-stranded RNA templates, initiating the production of transitive siRNAs. In Arabidopsis, RDR1 and RDR6 are primarily involved in this process.
What are the biological functions of transitive siRNAs?
Transitive siRNAs play crucial roles in plant development, stress responses, and defense against viruses. They also contribute to the regulation of gene expression through posttranscriptional gene silencing and can influence epigenetic modifications.
Why are transitive siRNAs important for agriculture?
Understanding transitive siRNA mechanisms can help in developing crops with improved stress tolerance, pathogen resistance, and desirable traits through targeted gene silencing, offering potential biotechnological applications.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.